TrialBMC cancer2014

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

Antonio Avallone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.